Insider screener

Period: 12 months Role: 10% owners × Plan: Scheduled (10b5-1) × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

770 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

770 decisions over 12 months Remove this filter
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

770 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

770 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
770 decisions over 12 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
770 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

770 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
24 Nov 2025
Sold on a plan 3×
$16.94M 317,125 at 53.41
32.5%
Planned (10b5-1)
24 Nov 2025
Sold on a plan 3×
$2.67M 35,000 at 76.36
0.5%
Planned (10b5-1)
24 Nov 2025
SVF Endurance (Cayman) Ltd 10% owner · indirect
Sold on a plan
$1.40M 227,803 at 6.15
1.6%
Planned (10b5-1)
24 Nov 2025
GADICKE ANSBERT 10% owner · indirect
Sold on a plan
$87.03K 88,802 at 0.98
1.7%
Planned (10b5-1)
24 Nov 2025
MPM BioVentures 2014, L.P. 10% owner · indirect
Sold on a plan
$87.03K 88,802 at 0.98
1.7%
Planned (10b5-1)
21 Nov 2025
Sold on a plan 3×
$2.17M 29,167 at 74.26
0.4%
Planned (10b5-1)
21 Nov 2025
GADICKE ANSBERT 10% owner · indirect
Sold on a plan
$53.39K 64,331 at 0.83
1.2%
Planned (10b5-1)
21 Nov 2025
MPM BioVentures 2014, L.P. 10% owner · indirect
Sold on a plan
$53.39K 64,331 at 0.83
1.2%
Planned (10b5-1)
20 Nov 2025
GADICKE ANSBERT 10% owner · indirect
Sold on a plan
$36.63K 41,152 at 0.89
0.8%
Planned (10b5-1)
20 Nov 2025
MPM BioVentures 2014, L.P. 10% owner · indirect
Sold on a plan
$36.63K 41,152 at 0.89
0.8%
Planned (10b5-1)
19 Nov 2025
GADICKE ANSBERT 10% owner · indirect
Sold on a plan
$62.34K 66,324 at 0.94
1.2%
Planned (10b5-1)
19 Nov 2025
MPM BioVentures 2014, L.P. 10% owner · indirect
Sold on a plan
$62.34K 66,324 at 0.94
1.2%
Planned (10b5-1)
19 Nov 2025
Sold on a plan
$26.25K 25,000 at 1.05
11.1%
Planned (10b5-1)
18 Nov 2025
Sold on a plan 2×
$3.65M 47,901 at 76.13
0.7%
Planned (10b5-1)
18 Nov 2025
O'Neil Kevin Wayne 10% owner
Bought on a plan 22×
$461.72K 55,000 at 8.39
2.6%
Bought on a plan
18 Nov 2025
GADICKE ANSBERT 10% owner · indirect
Sold on a plan
$48.94K 52,627 at 0.93
1.0%
Planned (10b5-1)
18 Nov 2025
MPM BioVentures 2014, L.P. 10% owner · indirect
Sold on a plan
$48.94K 52,627 at 0.93
1.0%
Planned (10b5-1)
18 Nov 2025
Sold on a plan
$28.75K 25,000 at 1.15
10.0%
Planned (10b5-1)
17 Nov 2025
Sold on a plan 3×
$1.44M 18,599 at 77.67
0.3%
Planned (10b5-1)
17 Nov 2025
GADICKE ANSBERT 10% owner · indirect
Sold on a plan
$54.21K 57,061 at 0.95
1.0%
Planned (10b5-1)
17 Nov 2025
MPM BioVentures 2014, L.P. 10% owner · indirect
Sold on a plan
$54.21K 57,061 at 0.95
1.0%
Planned (10b5-1)
14 Nov 2025
GADICKE ANSBERT 10% owner · indirect
Sold on a plan
$57.33K 61,640 at 0.93
1.1%
Planned (10b5-1)
14 Nov 2025
MPM BioVentures 2014, L.P. 10% owner · indirect
Sold on a plan
$57.33K 61,640 at 0.93
1.1%
Planned (10b5-1)
13 Nov 2025
GADICKE ANSBERT 10% owner · indirect
Sold on a plan
$89.13K 90,951 at 0.98
1.6%
Planned (10b5-1)
13 Nov 2025
MPM BioVentures 2014, L.P. 10% owner · indirect
Sold on a plan
$89.13K 90,951 at 0.98
1.6%
Planned (10b5-1)
12 Nov 2025
GADICKE ANSBERT 10% owner · indirect
Sold on a plan
$44.33K 40,669 at 1.09
0.7%
Planned (10b5-1)
12 Nov 2025
MPM BioVentures 2014, L.P. 10% owner · indirect
Sold on a plan
$44.33K 40,669 at 1.09
0.7%
Planned (10b5-1)
12 Nov 2025
Sold on a plan
$35.25K 25,000 at 1.41
33.3%
Planned (10b5-1)
11 Nov 2025
GADICKE ANSBERT 10% owner · indirect
Sold on a plan
$63.62K 55,810 at 1.14
1.0%
Planned (10b5-1)
11 Nov 2025
MPM BioVentures 2014, L.P. 10% owner · indirect
Sold on a plan
$63.62K 55,810 at 1.14
1.0%
Planned (10b5-1)
11 Nov 2025
Sold on a plan
$34.25K 25,000 at 1.37
25.0%
Planned (10b5-1)
10 Nov 2025
Bayview Legacy, LLC 10% owner · indirect
Sold on a plan
$736.83K 50,000 at 14.74
0.5%
Planned (10b5-1)
10 Nov 2025
GADICKE ANSBERT 10% owner · indirect
Sold on a plan
$57.31K 48,570 at 1.18
0.8%
Planned (10b5-1)
10 Nov 2025
MPM BioVentures 2014, L.P. 10% owner · indirect
Sold on a plan
$57.31K 48,570 at 1.18
0.8%
Planned (10b5-1)
7 Nov 2025
GADICKE ANSBERT 10% owner · indirect
Sold on a plan
$76.01K 68,480 at 1.11
1.2%
Planned (10b5-1)
7 Nov 2025
MPM BioVentures 2014, L.P. 10% owner · indirect
Sold on a plan
$76.01K 68,480 at 1.11
1.2%
Planned (10b5-1)
6 Nov 2025
GADICKE ANSBERT 10% owner · indirect
Sold on a plan
$65.89K 54,452 at 1.21
0.9%
Planned (10b5-1)
6 Nov 2025
MPM BioVentures 2014, L.P. 10% owner · indirect
Sold on a plan
$65.89K 54,452 at 1.21
0.9%
Planned (10b5-1)
5 Nov 2025
GADICKE ANSBERT 10% owner · indirect
Sold on a plan
$58.50K 47,950 at 1.22
0.8%
Planned (10b5-1)
5 Nov 2025
MPM BioVentures 2014, L.P. 10% owner · indirect
Sold on a plan
$58.50K 47,950 at 1.22
0.8%
Planned (10b5-1)
5 Nov 2025
Sold on a plan
$49.50K 25,000 at 1.98
20.0%
Planned (10b5-1)
4 Nov 2025
GADICKE ANSBERT 10% owner · indirect
Sold on a plan
$171.40K 140,488 at 1.22
2.3%
Planned (10b5-1)
4 Nov 2025
MPM BioVentures 2014, L.P. 10% owner · indirect
Sold on a plan
$171.40K 140,488 at 1.22
2.3%
Planned (10b5-1)
4 Nov 2025
Sold on a plan
$46.75K 25,000 at 1.87
16.7%
Planned (10b5-1)
3 Nov 2025
GADICKE ANSBERT 10% owner · indirect
Sold on a plan
$121.34K 94,063 at 1.29
1.5%
Planned (10b5-1)
3 Nov 2025
MPM BioVentures 2014, L.P. 10% owner · indirect
Sold on a plan
$121.34K 94,063 at 1.29
1.5%
Planned (10b5-1)
31 Oct 2025
GADICKE ANSBERT 10% owner · indirect
Sold on a plan
$145.98K 114,044 at 1.28
1.8%
Planned (10b5-1)
31 Oct 2025
MPM BioVentures 2014, L.P. 10% owner · indirect
Sold on a plan
$145.98K 114,044 at 1.28
1.8%
Planned (10b5-1)
30 Oct 2025
GADICKE ANSBERT 10% owner · indirect
Sold on a plan
$124.32K 86,936 at 1.43
1.3%
Planned (10b5-1)
30 Oct 2025
MPM BioVentures 2014, L.P. 10% owner · indirect
Sold on a plan
$124.32K 86,936 at 1.43
1.3%
Planned (10b5-1)
Showing 701–750 of 770. ← Newer Page 15 of 16 Older →